These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6146795)

  • 1. Imaging of medullary thyroid cancer with 131I-MIBG.
    Endo K; Shiomi K; Kasagi K; Konishi J; Torizuka K; Nakao K; Tanimura H
    Lancet; 1984 Jul; 2(8396):233. PubMed ID: 6146795
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of metastatic medullary thyroid cancer with 131I-MIBG scans in Sipple's syndrome.
    Itoh H; Sugie K; Toyooka S; Kawase M; Mukaino S; Hazama F; Endo K; Torizuka K; Nakao K; Imura H
    Eur J Nucl Med; 1986; 11(12):502-4. PubMed ID: 2874028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitfall of Sipple's syndrome diagnosis by 131I-metaiodobenzylguanidine (MIBG).
    Talbot JN; Coutris G; Moulonguet M; Hoang C; Perniceni T; Milhaud G
    J Nucl Med Allied Sci; 1987; 31(4):337-40. PubMed ID: 2895168
    [No Abstract]   [Full Text] [Related]  

  • 4. Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.
    Poston GJ; Thomas AM; Macdonald DW; Karvounaris D; Henderson BL; George P; Lynn JA; Lavender JP
    Nucl Med Commun; 1986 Apr; 7(4):215-21. PubMed ID: 2873544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging and uptake mechanism of 131I-meta-iodobenzylguanidine in medullary thyroid carcinoma.
    Oishi S; Sasaki M; Sato T; Hirota Y; Takahashi M
    Endocrinol Jpn; 1986 Jun; 33(3):309-15. PubMed ID: 2875869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid uptake of MIBG in Sipple's syndrome.
    Perdrisot R; Rohmer V; Lejeune JJ; Bigorgne JC; Jallet P
    Eur J Nucl Med; 1988; 14(1):37-8. PubMed ID: 2898364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-131 MIBG uptake in metastatic medullary carcinoma of the thyroid. A patient treated with somatostatin.
    Keeling CA; Basso LV
    Clin Nucl Med; 1988 Apr; 13(4):260-3. PubMed ID: 2897264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical applications of 131I-meta iodobenzylguanidine (131I-MIBG) scintigraphy in Japan].
    Izumi M; Kakezono F; Nagayama Y; Kiriyama T; Yokoyama N; Yamashita S; Morita S; Hirayu H; Kubo I; Ohtakara S
    Kaku Igaku; 1986 Feb; 23(2):145-52. PubMed ID: 2872353
    [No Abstract]   [Full Text] [Related]  

  • 9. Medullary thyroid carcinoma: localization of a mediastinal metastasis with I-131 MIBG.
    Laflamme L; Taillefer R; Duranceau A; Verdy M; Schürch W
    Clin Nucl Med; 1988 Aug; 13(8):577-9. PubMed ID: 2901928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
    Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
    Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 131I-MIBG and medullary carcinoma of the thyroid.
    Connell JM; Hilditch TE; Elliott A; Semple PF
    Lancet; 1984 Dec; 2(8414):1273-4. PubMed ID: 6150300
    [No Abstract]   [Full Text] [Related]  

  • 12. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
    Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
    J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
    Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
    J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study.
    Baulieu JL; Guilloteau D; Delisle MJ; Perdrisot R; Gardet P; Delépine N; Baulieu F; Dupont JL; Talbot JN; Coutris G
    Cancer; 1987 Nov; 60(9):2189-94. PubMed ID: 2894239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
    Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
    J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of 131I-MIBG by medullary carcinoma of thyroid in familial cases.
    Coutris G; Talbot JN; Kabla G; Calmettes C; Milhaud G
    Eur J Nucl Med; 1986; 12(2):77-9. PubMed ID: 3732310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
    Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
    J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of medullary thyroid carcinoma and hyperfunctioning adrenal medulla using iodine-131 metaiodobenzylguanidine.
    Ansari AN; Siegel ME; DeQuattro V; Gazarian LH
    J Nucl Med; 1986 Dec; 27(12):1858-60. PubMed ID: 2878066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodology and dosimetry in adrenal medullary imaging with iodine-131 MIBG.
    Lindberg S; Fjälling M; Jacobsson L; Jansson S; Tisell LE
    J Nucl Med; 1988 Oct; 29(10):1638-43. PubMed ID: 2902204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [I-131-meta-iodobenzylguanidine and multiple endocrine adenomatosis type II].
    Simó R; Mesa J
    Med Clin (Barc); 1987 Dec; 89(20):888. PubMed ID: 2896282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.